Send feedback

EVC2 p.Pro3=

c.9C>T · rs573858756 · VCV1647459

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00863%, eas)
Conditions
2
Ellis-van Creveld syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -1.4GERP -2.6
Overall
CADD4.516PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00863% East Asian · 3/34,776 alleles
Filtering AF 0.00229% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00123%
Overall 0.000474% 7/1,476,544 alleles · very rare exomes 5/1,324,334 · genomes 2/152,210 · joint denominator
Ancestry group Frequency 1 in
East Asiangrpmax 0.00863% 11,592
African / African-American 0.00147% 68,092
South Asian 0.00129% 77,232
European (non-Finnish) 0.000178% 560,730

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EVC2
Protein
p.Pro3=
Coding
c.9C>T
MANE Select
NM_147127
dbSNP
rs573858756
Type
single nucleotide variant
Location
chr4:5708505 (GRCh38)
Gene constraint
LOEUF 1.092 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 73.33
Full EVC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/evc2-p-pro3 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown